DL-δ-Hydroxynorvaline

DL-δ-Hydroxynorvaline contains a five-carbon norvaline backbone bearing a stereogenic center at the α-position and a hydroxyl substituent at the δ-position, giving a chiral amino acid framework with a primary alcohol functional group. DL-δ-Hydroxynorvaline is present as a racemic mixture (DL), which influences stereochemical outcomes in peptide coupling and downstream structure-function studies, while the amino and carboxyl functionalities support standard amino acid derivative chemistry. The side-chain hydroxyl can participate in hydrogen bonding and can be selectively protected or converted to activated leaving groups, enabling controlled derivatization without disrupting the amino acid core. As an amino acid-based intermediate, DL-δ-Hydroxynorvaline can be transformed into protected amino acid derivatives or activated forms suitable for peptide bond formation and for conversion into functionalized building blocks for synthetic organic chemistry and biochemical research.

1. Peptide Synthesis

DL-δ-Hydroxynorvaline is applied in peptide building block preparation where the α-amino and α-carboxyl groups enable peptide coupling after appropriate N- and C-terminal protection strategies. The δ-hydroxyl side-chain can be protected as an ether or ester to prevent side reactions during coupling, and the racemic nature supports parallel synthesis of stereochemical variants when stereodefined analogs are not required. Amino acid ester or activated acid derivatives derived from DL-δ-Hydroxynorvaline can be employed to construct peptide sequences by standard amide bond-forming chemistry, with the side-chain alcohol serving as a functional handle for post-coupling modification. Peptide analogs incorporating this residue can be used to probe hydrogen-bonding patterns and conformational effects in peptide science and peptidomimetic construction.

2. Amino Acid Derivatization

DL-δ-Hydroxynorvaline supports amino acid derivatization workflows that capitalize on the unprotected or selectively protected side-chain hydroxyl for functional group interconversions. The δ-alcohol can be converted into esters, carbamates, or other protected forms to tune polarity and reactivity, and can be further transformed into leaving-group-bearing intermediates for substitution chemistry. The amino acid backbone enables formation of N-protected derivatives and carboxyl-activated intermediates, supporting downstream synthetic routes that require controlled chemoselectivity between the α-amino, α-carboxyl, and δ-hydroxyl sites. Resulting derivatives can serve as intermediates for fine chemical synthesis, chiral precursor generation, or scaffold diversification in medicinal chemistry and chemical biology programs.

3. Chemical Biology Probes

DL-δ-Hydroxynorvaline is suitable for chemical biology research where hydroxyl-bearing amino acid residues can be used to model polar side-chain interactions in biomolecular recognition. The presence of a side-chain alcohol at the δ-position enables conjugation-compatible handles after protection/deprotection or conversion to activated intermediates, supporting incorporation into peptide probes, enzyme substrate analogs, or affinity reagents. Racemic availability can be used to generate stereochemical libraries for mapping interaction specificity, while subsequent resolution or stereoselective synthesis can be applied when enantiopure materials are required. Downstream functionalization of the hydroxyl group can enable attachment of tags for biochemical assays or for studying binding and processing behavior of amino acid-containing constructs.

4. Process Chemistry Intermediate

DL-δ-Hydroxynorvaline is employed as a process chemistry intermediate for manufacturing routes that require an amino acid scaffold with a functional side-chain suitable for controlled protection and activation steps. The amino and carboxyl functionalities allow conversion into N-protected amino acid derivatives and carboxyl-activated intermediates, supporting scalable peptide coupling feedstocks and intermediate preparation for specialty chemical production. The δ-hydroxyl group can be managed through orthogonal protection strategies to minimize byproduct formation during sequential synthesis steps, including protection, coupling, and late-stage functional group transformation. Industrial utilization can include preparation of hydroxyl-functional amino acid derivatives used in peptide-manufacturing workflows, as well as generation of downstream building blocks for polymer modification and functional material precursors.

5. Analytical Standards

DL-δ-Hydroxynorvaline can be used for analytical research as a reference material for method development and characterization of amino acid derivatives, protected building blocks, and peptide fragments containing a δ-hydroxynorvaline residue. The racemic composition provides a practical standard for assessing stereochemical mixtures by chromatographic or spectrometric techniques, while the side-chain hydroxyl contributes characteristic derivatization behavior for detection workflows. Conversion to protected derivatives or derivatized forms can support calibration of analytical methods targeting amino acid ester/acid forms, N-protected intermediates, or hydroxyl-functional peptide components. Analytical use of DL-δ-Hydroxynorvaline supports quality control and structural verification in peptide science, biochemical research intermediate tracking, and synthetic route monitoring.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

3. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

4. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

5. The spatiotemporal control of signalling and trafficking of the GLP-1R